先锋新材(300163) - 2020 Q1 - 季度财报

Financial Performance - Total revenue for Q1 2020 was ¥49,899,056.75, a decrease of 65.75% compared to ¥145,670,734.18 in the same period last year[8] - Net profit attributable to shareholders was -¥600,905.30, representing a decline of 125.51% from ¥2,355,202.92 year-on-year[8] - Basic and diluted earnings per share were both -¥0.0013, down 126.00% from ¥0.005 in the same period last year[8] - The total profit for the period was 0.3433 million yuan, down 86.20% year-on-year[16] - The net profit attributable to the parent company was -0.6009 million yuan, representing a decline of 125.51% compared to the previous year[16] - The decline in performance was primarily due to the sale of KRS company and the impact of the COVID-19 pandemic, which led to a reduction in orders[16] - The net profit for Q1 2020 was a loss of CNY 669,041.17, compared to a profit of CNY 742,135.31 in Q1 2019, indicating a shift in financial performance[36] - The net profit for Q1 2020 was a loss of ¥728,889.04, compared to a profit of ¥7,249,666.80 in Q1 2019, indicating a significant decline in profitability[40] - The total comprehensive income attributable to the parent company was -¥600,905.30, a sharp decline from ¥2,168,414.22 in the same period last year[40] Cash Flow and Liquidity - Net cash flow from operating activities was -¥19,033,997.53, a significant decrease of 2,309.64% compared to ¥861,406.38 in the previous year[8] - The cash flow from operating activities showed a net outflow of -¥19,033,997.53, compared to a slight inflow of ¥861,406.38 in Q1 2019[44] - The company's total cash and cash equivalents at the end of Q1 2020 were ¥41,698,770.36, down from ¥61,548,126.37 at the beginning of the quarter[45] - Cash outflow from operating activities totaled 114,188,000.76, compared to 73,187,340.30 in the previous period, indicating higher operational costs[47] - The cash inflow from operating activities totaled 98,045,460.93, compared to 82,718,979.22 in the previous period, indicating improved sales performance[47] - The company's cash and cash equivalents at the end of the period amounted to 13,050,140.17, compared to 12,704,446.30 in the previous period, showing a slight increase[48] Assets and Liabilities - Total assets at the end of the reporting period were ¥794,696,479.34, a decrease of 1.86% from ¥809,725,739.53 at the end of the previous year[8] - The total assets as of March 31, 2020, were CNY 927,385,911.77, down from CNY 999,746,774.65 at the end of 2019, reflecting a decline in overall asset base[32] - The total liabilities decreased from 228.59 million yuan to 214.23 million yuan during the same period[28] - Total liabilities decreased to CNY 205,592,899.97 from CNY 277,224,873.81, indicating a reduction in financial obligations[32] - The company's equity attributable to shareholders was CNY 578,667,547.89, slightly down from CNY 579,268,453.19, showing stability in shareholder equity despite losses[31] Operational Changes - Revenue and cost of goods sold decreased by 65.75% and 57.46% respectively, primarily due to the divestiture of KRS company, which is no longer included in the current reporting[14] - The balance of accounts receivable financing decreased by 79.54% compared to the end of the previous year, mainly due to the endorsement transfer of notes receivable[14] - Prepaid expenses increased by 42.89% compared to the end of the previous year, primarily due to increased advance payments for material purchases[14] - Other income decreased by 47.42% year-on-year, mainly due to a reduction in project subsidies received[15] - The company had a total of 19,852 common shareholders at the end of the reporting period[10] - The company had no significant changes in major suppliers or customers during the reporting period[17] - There were no major changes in intangible assets or core competencies reported[17] - The company reported no violations regarding external guarantees during the reporting period[19] Research and Development - The company reported a significant increase in research and development expenses to CNY 1,888,882.41 from CNY 2,256,858.23, highlighting ongoing investment in innovation[35] - Research and development expenses for Q1 2020 were ¥1,888,882.41, a decrease of 16.3% from ¥2,256,858.23 in the previous year[39] Financial Management - The total amount of non-operating fund occupation by major shareholders and related parties was 51.27 million yuan, with 16.35 million yuan repaid during the period[20] - The financial expenses for Q1 2020 were significantly reduced to ¥31,675.40 from ¥1,637,831.65 in Q1 2019[39] - The company incurred sales expenses of ¥923,251.55, down from ¥1,934,596.06 in the previous year, reflecting cost-cutting measures[39] - The company reported a credit impairment loss of ¥4,874,033.45, compared to ¥1,444,035.93 in the same period last year, indicating increased credit risk[40] Audit and Compliance - The company did not undergo an audit for the first quarter report[49] - The company did not apply new revenue and leasing standards for the current period[49]